We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Shire “Encouraged” By Settlement Talks Over Adderall

Law360 (April 27, 2006, 12:00 AM EDT) -- After months of negotiations, U.K. drug maker Shire Pharmaceuticals said this week it remains optimistic about talks with Barr Laboratories to try to settle out of court a patent challenge to Shire’s blockbuster hyperactivity drug Adderall XR.

The two companies are involved in litigation concerning Barr's efforts to market a copycat version of Shire's Adderall XR prior to the expiration of the Shire patents, which are not set to expire until 2018.

The two companies have remained tight-lipped concerning the negotiations, which have been ongoing since...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.